Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Social media users are claiming berberine, a dietary supplement, to be "nature's Ozempic." Can it be used for weight loss?

Glipizide tablet, extended release: Pfizer and Teva have discontinued multiple presentations of glipizide extended-release tablet, used in endocrinology and metabolism. The decision to discontinue ...

Adults with T2D taking semaglutide, other glucagon-like peptide 1 receptor agonists (GLP-1 RAs; dulaglutide and exenatide), or non-GLP-1 RA medications (empagliflozin, sitagliptin, and glipizide ...

Data Synthesis: Studies of glyburide and glipizide have found little or no transfer of these drugs across the placenta, whereas metformin and rosiglitazone cross readily. Animal studies have found ...

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...